Performance analysis of Cardiff Oncology (CRDF)
Annual Return
Over the past 3 years, CRDF has had an average annual return of -17.84%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, CRDF has had an average annual return of -31.47%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, CRDF has had an average annual return of -45.72%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Jul 27, 2004, CRDF has had an average annual return of -29.22%, underperforming the benchmark SPY, which returned +11.11% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -70.59% | -37.04% | +200% | +0% | -75.68% | -66.67% | +1,287.50% | -57.89% | -86.13% | -85.32% | -61.13% | +25.59% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
| -25.09% | -17.18% | +109.95% | +5.84% | -30.70% | +130.68% | -51.48% | -38.53% | -40.76% | -54.00% | +6.67% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -35.29% | +9.09% | -16.67% | +10% | +9.09% | -33.33% | -37.50% | -70.59% | |||||
| 2025 | -7.41% | +4% | -26.92% | -10.53% | +23.53% | -9.52% | -21.05% | -13.33% | +0% | +15.38% | -6.67% | +21.43% | -37.04% |
| 2024 | +11.11% | +10% | +200% | -18.18% | -25.93% | -30.00% | -0% | +0% | +14.29% | +18.75% | -15.79% | +68.75% | +200% |
| 2023 | +22.22% | +0% | -9.09% | +10% | -9.09% | -10.00% | +22.22% | -0% | -18.18% | -22.22% | +14.29% | +12.50% | +0% |
| 2022 | -43.24% | -19.05% | -11.76% | -46.67% | +0% | +75% | -0% | +21.43% | -41.18% | +0% | +0% | -10.00% | -75.68% |
| 2021 | -34.23% | -12.33% | -10.94% | +7.02% | -14.75% | -21.15% | -19.51% | +36.36% | -8.89% | -12.20% | -2.78% | +5.71% | -66.67% |
| 2020 | +25% | -20.00% | -25.00% | +33.33% | +87.50% | +106.67% | -3.23% | +63.33% | +79.59% | +11.36% | +56.12% | -27.45% | +1,287.50% |
| 2019 | +31.58% | -20.00% | +15% | -4.35% | -18.18% | -16.67% | -26.67% | +9.09% | -25.00% | +22.22% | -18.18% | -11.11% | -57.89% |
| 2018 | -15.33% | +16.38% | +14.81% | -19.35% | -14.40% | -72.90% | -0% | +3.45% | -0% | -13.33% | -0% | -26.92% | -86.13% |
| 2017 | -4.72% | -2.47% | -41.06% | -19.18% | -30.75% | +95.80% | -35.71% | -18.61% | +10.58% | -2.47% | -15.51% | -48.69% | -85.32% |
Drawdown analysis of Cardiff Oncology (CRDF)
The maximum drawdown for the CRDF was -99.96%, occurring on Mar 16, 2020. This drawdown has not yet recovered.
The current CRDF drawdown is -99.96%.
Since Jul 27, 2004 CRDF has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.96% | Jun 8, 2005 | 3717 | Mar 16, 2020 | Ongoing | Ongoing | Ongoing |
| -42.53% | Nov 23, 2004 | 78 | Mar 17, 2005 | 57 | Jun 8, 2005 | 135 |
| -5.88% | Nov 12, 2004 | 6 | Nov 22, 2004 | 1 | Nov 23, 2004 | 7 |
| -1.31% | Aug 11, 2004 | 41 | Oct 8, 2004 | 17 | Nov 2, 2004 | 58 |